Peptide record

TPDB77622

Vapreotide Blood-Brain Barrier modified_plain modified
12 source-reported length (unverified)
Basic Information
TPDB77622
Vapreotide
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
Peptipedia
modified_plain
Yes
A modified blood-brain barrier peptide record curated from Peptipedia, without an available 3D structural model. Source-reported length: 12 (unverified).
C-terminal: Amidation Chemical: Cys2-Cys7
Sequence
fCYwKVCW-NH2

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
12 source-reported length (unverified)
Cys2-Cys7 Activity
Linear Activity
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Trp-NH2 Activity
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)Cc7c6ccccc6nc7 Activity
Evidence Records 8 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.0000923 mL/(g x min)

Assay & Model

Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
non saturable
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.0137 ml/g

Assay & Model

Initial distribution volume

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Permeability
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
1.05 min

Assay & Model

half life, serum

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Permeability
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
24 min

Assay & Model

Efflux study ICU
half life, brain

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Permeability
Direct iodination
Evidence 5 Activity

Activity

Blood-Brain Barrier
0.029 min-1

Assay & Model

Efflux study ICU
Brain elemination rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Saturable
Direct iodination
Evidence 6 Activity

Activity

Blood-Brain Barrier
20.3 µL/(g x min)

Assay & Model

Permeability surface area cofficient

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
in situ brain perfusion
non saturable
Direct iodination
Evidence 7 Activity

Activity

Blood-Brain Barrier
41.6 %/g

Assay & Model

HPLC
% injected dose

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 8 Activity

Activity

Blood-Brain Barrier
36.9 %/g

Assay & Model

HPLC
% injected dose

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Additional Detail Fields 1 fields
Intravenous in situ brain perfusion